Call to action: a five nations consensus on the use of intravenous zoledronate after hip fracture

Currently in the UK and Ireland, after a hip fracture most patients do not receive bone protection medication to reduce the risk of refracture. Yet randomised controlled trial data specifically examining patients with hip fracture have shown that intravenous zoledronate reduces refracture risk by a...

Descripción completa

Detalles Bibliográficos
Autores principales: Johansen, Antony, Sahota, Opinder, Dockery, Frances, Black, Alison J, MacLullich, Alasdair M J, Javaid, M Kassim, Ahern, Emer, Gregson, Celia L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Guidelines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542103/
https://www.ncbi.nlm.nih.gov/pubmed/37776543
http://dx.doi.org/10.1093/ageing/afad172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542103/
https://www.ncbi.nlm.nih.gov/pubmed/37776543
http://dx.doi.org/10.1093/ageing/afad172

Ejemplares similares